Iofina Regulatory News (IOF)

6 September 2013

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

Notice of Interim Results

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, announces that its interim results for the six months ended 30 June 2013 will be published on 25 September 2013.

A presentation for retail investors will be held at The Grange St Paul's Hotel, 10 Godliman Street, London, EC4V 5AJ on Wednesday 25 September 2013 at 2.00 p.m.

For further information, please contact:

Dr. Chris Fay, Executive Chairman

Iofina plc

Tel: +44(0)20 3006 3135

www.iofina.com

Ben Colegrave/Chris Sim/James Rudd

Investec

Tel: +44(0)20 7597 5970

Media Contact:

Dominic Barretto

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739

About Iofina

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.